Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Retained Earnings (2021 - 2025)

PAVmed (PAVM) has 5 years of Retained Earnings data on record, last reported at -$256.9 million in Q3 2025.

  • For Q3 2025, Retained Earnings changed N/A year-over-year to -$256.9 million; the TTM value through Sep 2025 reached -$256.9 million, changed N/A, while the annual FY2024 figure was -$255.0 million, 13.4% up from the prior year.
  • Retained Earnings reached -$256.9 million in Q3 2025 per PAVM's latest filing, down from -$250.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$97.8 million in Q1 2021 and bottomed at -$320.6 million in Q2 2024.
  • Average Retained Earnings over 5 years is -$219.5 million, with a median of -$241.7 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: tumbled 70.72% in 2022, then increased 23.39% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$138.9 million in 2021, then crashed by 64.26% to -$228.2 million in 2022, then dropped by 29.04% to -$294.4 million in 2023, then increased by 13.4% to -$255.0 million in 2024, then fell by 0.76% to -$256.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$256.9 million in Q3 2025, -$250.6 million in Q2 2025, and -$237.3 million in Q1 2025.